New injection for lupus enters first safety tests in humans
NCT ID NCT07323173
First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This early-stage study tests a single injection of a new drug, LBL-047, in healthy adults and people with mild-to-moderate systemic lupus erythematosus (lupus). The main goal is to check for side effects and how the drug moves through the body. About 112 participants will receive either the drug or a placebo, and the results will help decide if further testing is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mianyang Central Hospital
NOT_YET_RECRUITINGMianyang, Sichuan, 621051, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanjing Drum Tower Hospital
NOT_YET_RECRUITINGNanjing, Jiangsu, 210008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pingxiang People's Hospital
NOT_YET_RECRUITINGPingxiang, Jiangxi, 337099, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai JiaoTong University School of Medicine，Renji Hospital
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Public Health Clinical Center
RECRUITINGShanghai, Shanghai Municipality, 200083, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanxi Bethune Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, 030032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Bengbu Medical University
NOT_YET_RECRUITINGBengbu, Anhui, 233004, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Xian Jiaotong University
NOT_YET_RECRUITINGXian, Shanxi, 710004, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
West China Hospital of Sichuan University
NOT_YET_RECRUITINGChengdu, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangya School of Medicine of Central South University
NOT_YET_RECRUITINGChangsha, Hunan, 410028, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.